Hormone Replacement Therapy and Pain: How HRT and TRT Can Help (or Hinder) Pain Management in Rheumatic Disease and Fibromyalgia

Balanced review of HRT/TRT and pain in rheumatic disease & fibromyalgia: mechanisms, benefits, risks, routes, and UK‑specific guidance.

Who is this for?
Adults living with a chronic rheumatological condition (e.g., rheumatoid arthritis, axial spondyloarthritis, lupus) or fibromyalgia who want to understand how hormone replacement therapy (HRT) for women and testosterone replacement therapy (TRT) for men might affect pain. This article is information only—please discuss personal decisions with your GP or specialist.

The short answer

HRT and pain: HRT is primarily used for menopause symptoms (hot flushes, night sweats, vaginal dryness). Some women also notice modest improvements in joint or muscle pain, especially with oestrogen‑only HRT after hysterectomy, but HRT is not a stand‑alone pain treatment. Benefits must be weighed against individual risks (e.g., clots, stroke, breast risk).
TRT and pain (men): TRT is only for men with proven low testosterone and symptoms. It may improve pain sensitivity and energy in opioid‑induced low testosterone, and it can help muscle and bone health; however, it is not a painkiller. Regular monitoring is essential.
Fibromyalgia: HRT might help some post‑menopausal women indirectly (better sleep, fewer night sweats), but it is not first‑line. Core fibromyalgia care still includes exercise, sleep and mood support, and pain education.

How can hormones affect pain?

Oestrogen receptors sit in the spinal cord and brain areas that process pain; changing oestrogen levels can raise or lower pain sensitivity.
Progesterone can be converted to a calming brain chemical (allopregnanolone) that boosts the activity of GABA, the main “brake” system in the nervous system—this can reduce pain signals in lab models.
Testosterone supports muscle and bone; low levels are linked with reduced lean mass and lower bone density, which can worsen physical function and some kinds of pain.

What does the evidence show for women?

1) Menopausal aches and joint pain

Large studies show mixed results overall, but in the Women’s Health Initiative, women on oestrogen‑only HRT (after hysterectomy) reported slightly less joint pain than placebo; the difference was modest but persisted over time.
Overall, HRT should be prescribed for menopausal symptoms, not purely to treat unexplained pain—though some people do notice secondary benefits.

2) Safer ways to take HRT if you’re at higher risk

In UK guidance, skin (transdermal) oestrogen patches/gels have a lower clot (VTE) risk than oral tablets and are often preferred when clot or cardiovascular risk is a concern. Micronised progesterone or an LNG‑IUD are preferred for womb protection due to a more favourable clot profile.
Low‑dose vaginal oestrogen for dryness/bladder symptoms has minimal absorption and does not raise VTE risk.

3) Rheumatology cautions

Lupus/antiphospholipid antibodies (aPL): HRT can be considered for severe menopausal symptoms in stable lupus without aPL; avoid or be very cautious if aPL positive or with high clot risk—specialist advice is essential.
Rheumatoid arthritis and other inflammatory arthritis: HRT does not treat the disease but may be used for menopausal symptoms after standard risk assessment. Keep to your usual DMARD/biologic plan.

4) Fibromyalgia

A small open study in post‑menopausal women reported improved fibromyalgia impact and sleep after 12 weeks of transdermal oestrogen + micronised progesterone; this is encouraging but not definitive. HRT should not replace core fibromyalgia management.
UK guidance for chronic primary pain (which includes fibromyalgia) recommends exercise programmes, CBT/ACT‑style psychological support, and (in selected cases) acupuncture as first‑line options.

What does the evidence show for men?

1) When TRT helps

TRT should be considered only if you have clear symptoms plus repeatedly low morning testosterone on blood tests, after causes are assessed.
In men with opioid‑induced low testosterone, a trial of transdermal testosterone improved pain sensitivity (hyperalgesia) and sexual desire, though self‑rated pain scores did not change—so TRT may make nerves less sensitive but is not a direct painkiller.

2) Muscle and bone

TRT can increase lean body mass and hip bone density, which may indirectly improve function and some mechanical pain over time (especially in clearly hypogonadal men), but effects on strength/pain vary between studies.

3) Safety and monitoring

Do not use TRT if you have active prostate/breast cancer, very high haematocrit, untreated severe sleep apnoea, uncontrolled heart failure, or if you’re trying to conceive (TRT lowers sperm count). Regular monitoring of testosterone level, PSA, and haematocrit is required.

Is hormone therapy right for you? A quick checklist

For women considering HRT

Main goal: Are you treating troublesome menopausal symptoms (e.g., flushes/night sweats)? If yes, HRT may also indirectly help pain via better sleep and function.
Your risks: Any history of blood clots, stroke, migraine with aura, or high cardiovascular risk? If HRT is used, transdermal oestrogen and micronised progesterone/LNG‑IUD may be safer choices; seek clinician advice.
Autoimmune disease: If you have lupus, ask your specialist to check aPL status and current disease activity before starting HRT.
Timing: Starting within 10 years of menopause or before age 60 tends to have a better risk–benefit balance than starting later.

For men considering TRT

Confirm the diagnosis: Do you have typical symptoms (low sex drive, low energy, loss of morning erections) and consistently low morning testosterone on repeat tests? If not, TRT is unlikely to help and may harm.
Cause check: If you take long‑term opioids, ask about opioid‑induced androgen deficiency; if confirmed hypogonadism is present, TRT may improve pain sensitivity and vitality under supervision.
Monitoring: Agree a plan for PSA, haematocrit, and symptom checks at 3–6 months and yearly.

What not to expect

HRT or TRT will not replace your rheumatology medicines (e.g., methotrexate, biologics) or your fibromyalgia programme (exercise, sleep and psychological strategies). They are adjuncts (add-ons), not cures.
Hormone therapy won’t act like an opioid or anti‑inflammatory tablet; any pain improvements are usually modest and often arrive indirectly (sleep, mood, strength, bone health).

Questions to take to your appointment

What is my main goal? (flushes/night sweats, sleep, mood, sexual function, energy, bone health, or proven hypogonadism)
What’s my personal risk? (VTE/CVD risk for HRT; prostate/haematocrit for TRT) and what route/dose would you recommend?
How will we monitor safety and benefit? (review timing, blood tests, symptom goals)
How does this fit my pain plan? (exercise, sleep, CBT/ACT, and my rheumatology meds)

Trusted UK resources

British Menopause Society (BMS) – HRT Guides (for patients and clinicians).
NICE CKS – Menopause: HRT prescribing information (route and safety).
NICE NG193 – Chronic pain: assessment and management (including fibromyalgia).
Endocrine Society / AUA – Testosterone therapy guidelines (diagnosis, monitoring).

Bottom line

Hormone therapy can be helpful for the right reason, in the right person, via the right route, and with proper monitoring. It may ease pain indirectly by improving sleep, mood, and physical health, but it is not a primary pain treatment. A personalised plan—covering lifestyle, rehabilitation, psychological support, and disease‑specific medicines—remains the most effective way to manage long‑term pain.